Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

PARP1-dependent eviction of the linker histone H1 mediates immediate early gene expression during neuronal activation.

Azad GK, Ito K, Sailaja BS, Biran A, Nissim-Rafinia M, Yamada Y, Brown DT, Takizawa T, Meshorer E.

J Cell Biol. 2018 Feb 5;217(2):473-481. doi: 10.1083/jcb.201703141. Epub 2017 Dec 28.

2.

Alternative SET/TAFI Promoters Regulate Embryonic Stem Cell Differentiation.

Edupuganti RR, Harikumar A, Aaronson Y, Biran A, Sailaja BS, Nissim-Rafinia M, Azad GK, Cohen MA, Park JE, Shivalila CS, Markoulaki S, Sze SK, Jaenisch R, Meshorer E.

Stem Cell Reports. 2017 Oct 10;9(4):1291-1303. doi: 10.1016/j.stemcr.2017.08.021. Epub 2017 Sep 28.

3.

Heterochromatin Protein 1β (HP1β) has distinct functions and distinct nuclear distribution in pluripotent versus differentiated cells.

Mattout A, Aaronson Y, Sailaja BS, Raghu Ram EV, Harikumar A, Mallm JP, Sim KH, Nissim-Rafinia M, Supper E, Singh PB, Sze SK, Gasser SM, Rippe K, Meshorer E.

Genome Biol. 2015 Sep 28;16:213. doi: 10.1186/s13059-015-0760-8.

4.

Differential association of chromatin proteins identifies BAF60a/SMARCD1 as a regulator of embryonic stem cell differentiation.

Alajem A, Biran A, Harikumar A, Sailaja BS, Aaronson Y, Livyatan I, Nissim-Rafinia M, Sommer AG, Mostoslavsky G, Gerbasi VR, Golden DE, Datta A, Sze SK, Meshorer E.

Cell Rep. 2015 Mar 31;10(12):2019-31. doi: 10.1016/j.celrep.2015.02.064. Epub 2015 Mar 26.

5.

Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells.

Moussaieff A, Rouleau M, Kitsberg D, Cohen M, Levy G, Barasch D, Nemirovski A, Shen-Orr S, Laevsky I, Amit M, Bomze D, Elena-Herrmann B, Scherf T, Nissim-Rafinia M, Kempa S, Itskovitz-Eldor J, Meshorer E, Aberdam D, Nahmias Y.

Cell Metab. 2015 Mar 3;21(3):392-402. doi: 10.1016/j.cmet.2015.02.002.

6.

HP1 is involved in regulating the global impact of DNA methylation on alternative splicing.

Yearim A, Gelfman S, Shayevitch R, Melcer S, Glaich O, Mallm JP, Nissim-Rafinia M, Cohen AH, Rippe K, Meshorer E, Ast G.

Cell Rep. 2015 Feb 24;10(7):1122-34. doi: 10.1016/j.celrep.2015.01.038. Epub 2015 Feb 19.

7.

Non-polyadenylated transcription in embryonic stem cells reveals novel non-coding RNA related to pluripotency and differentiation.

Livyatan I, Harikumar A, Nissim-Rafinia M, Duttagupta R, Gingeras TR, Meshorer E.

Nucleic Acids Res. 2013 Jul;41(12):6300-15. doi: 10.1093/nar/gkt316. Epub 2013 Apr 29.

8.

Histone modifications and lamin A regulate chromatin protein dynamics in early embryonic stem cell differentiation.

Melcer S, Hezroni H, Rand E, Nissim-Rafinia M, Skoultchi A, Stewart CL, Bustin M, Meshorer E.

Nat Commun. 2012 Jun 19;3:910. doi: 10.1038/ncomms1915.

9.

H3K9 histone acetylation predicts pluripotency and reprogramming capacity of ES cells.

Hezroni H, Tzchori I, Davidi A, Mattout A, Biran A, Nissim-Rafinia M, Westphal H, Meshorer E.

Nucleus. 2011 Jul-Aug;2(4):300-9. doi: 10.4161/nucl.2.4.16767. Epub 2011 Jul 1.

10.

Photobleaching assays (FRAP & FLIP) to measure chromatin protein dynamics in living embryonic stem cells.

Nissim-Rafinia M, Meshorer E.

J Vis Exp. 2011 Jun 29;(52). pii: 2696. doi: 10.3791/2696.

11.

Nuclear lamins: key regulators of nuclear structure and activities.

Prokocimer M, Davidovich M, Nissim-Rafinia M, Wiesel-Motiuk N, Bar DZ, Barkan R, Meshorer E, Gruenbaum Y.

J Cell Mol Med. 2009 Jun;13(6):1059-85. doi: 10.1111/j.1582-4934.2008.00676.x. Epub 2009 Feb 4. Review.

12.

Stem cells do play with dice: a statistical physics view of transcription.

Efroni S, Melcer S, Nissim-Rafinia M, Meshorer E.

Cell Cycle. 2009 Jan 1;8(1):43-8. Epub 2009 Jan 16. Review.

PMID:
19106602
13.

Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.

Kerem E, Hirawat S, Armoni S, Yaakov Y, Shoseyov D, Cohen M, Nissim-Rafinia M, Blau H, Rivlin J, Aviram M, Elfring GL, Northcutt VJ, Miller LL, Kerem B, Wilschanski M.

Lancet. 2008 Aug 30;372(9640):719-27. doi: 10.1016/S0140-6736(08)61168-X. Epub 2008 Aug 20.

PMID:
18722008
14.

Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.

Linde L, Boelz S, Nissim-Rafinia M, Oren YS, Wilschanski M, Yaacov Y, Virgilis D, Neu-Yilik G, Kulozik AE, Kerem E, Kerem B.

J Clin Invest. 2007 Mar;117(3):683-92. Epub 2007 Feb 8.

15.

Splicing modulation as a modifier of the CFTR function.

Nissim-Rafinia M, Kerem B.

Prog Mol Subcell Biol. 2006;44:233-54.

PMID:
17076271
16.

The splicing machinery is a genetic modifier of disease severity.

Nissim-Rafinia M, Kerem B.

Trends Genet. 2005 Sep;21(9):480-3. Review.

PMID:
16039004
17.

Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation.

Nissim-Rafinia M, Aviram M, Randell SH, Shushi L, Ozeri E, Chiba-Falek O, Eidelman O, Pollard HB, Yankaskas JR, Kerem B.

EMBO Rep. 2004 Nov;5(11):1071-7.

18.

Splicing regulation as a potential genetic modifier.

Nissim-Rafinia M, Kerem B.

Trends Genet. 2002 Mar;18(3):123-7. Review.

PMID:
11858835
19.

Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations.

Nissim-Rafinia M, Chiba-Falek O, Sharon G, Boss A, Kerem B.

Hum Mol Genet. 2000 Jul 22;9(12):1771-8.

PMID:
10915765
20.

Screening of CFTR mutations in an isolated population: identification of carriers and patients.

Chiba-Falek O, Nissim-Rafinia M, Argaman Z, Genem A, Moran I, Kerem E, Kerem B.

Eur J Hum Genet. 1998 Mar-Apr;6(2):181-4.

21.

A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype.

Kerem E, Nissim-Rafinia M, Argaman Z, Augarten A, Bentur L, Klar A, Yahav Y, Szeinberg A, Hiba O, Branski D, Corey M, Kerem B.

Pediatrics. 1997 Sep;100(3):E5.

PMID:
9271620
22.

A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations.

Kerem E, Rave-Harel N, Augarten A, Madgar I, Nissim-Rafinia M, Yahav Y, Goshen R, Bentur L, Rivlin J, Aviram M, Genem A, Chiba-Falek O, Kraemer MR, Simon A, Branski D, Kerem B.

Am J Respir Crit Care Med. 1997 Jun;155(6):1914-20.

PMID:
9196095
23.

The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.

Rave-Harel N, Kerem E, Nissim-Rafinia M, Madjar I, Goshen R, Augarten A, Rahat A, Hurwitz A, Darvasi A, Kerem B.

Am J Hum Genet. 1997 Jan;60(1):87-94.

24.

CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens.

Rave-Harel N, Madgar I, Goshen R, Nissim-Rafinia M, Ziadni A, Rahat A, Chiba O, Kalman YM, Brautbar C, Levinson D, et al.

Am J Hum Genet. 1995 Jun;56(6):1359-66.

Supplemental Content

Loading ...
Support Center